Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Is The Combine Prolotherapy More Effective Than The Traditional Prolotherapy In Patients With Temporomandibular Joint Hypermobility?

NCT07020455 is registered in ClinicalTrials.gov with Karadeniz Technical University as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07020455 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Is The Combine Prolotherapy More Effective Than The Traditional Prolotherapy In Patients With Temporomandibular Joint Hypermobility?
Lead sponsor
Karadeniz Technical University
Phase
Phase 4
Overall status
Completed
Start date
January 1, 2019
Completion date
January 1, 2025
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arthrocentesis, hypermobility syndrome (disorder), hypermobility, joint, prolotherapy, temporomandibular disorders (tmd), temporomandibular pain